14th May 2021 11:21
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 Ordinary shares |
Date of dealing | 13 May 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
1,805,754 | 10.2000 GBP | 10.1600 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
156,824 | 10.1900 GBP | 10.1600 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swaps | Decrease Long
Decrease Short
Increase Short
Opening a long position
Opening a short position | 5,386 3,278 993 21
4,200 10
198,816 400 40,000 1,129 100,000 350,000 21,980 31,000
261
955,029 | 10.1831 GBP 10.1843 GBP 10.1878 GBP 10.1900 GBP
10.1698 GBP 10.1700 GBP
10.1699 GBP 10.1700 GBP 10.1721 GBP 10.1751 GBP 10.1752 GBP 10.1771 GBP 10.1801 GBP 10.1821 GBP
10.1850 GBP
10.1662 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 14 May 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L